New insulin set aims to last a full week – no more Every-Other-Day changes?

NCT ID NCT06273124

Completed Disease control Sponsor: Tandem Diabetes Care, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested a new insulin infusion set designed to be worn for up to 7 days instead of the usual 2-3 days. 260 adults with type 1 diabetes used the set at home for 12 wear periods. The goal was to see if the set could safely deliver insulin for a full week without causing high blood sugar or other problems.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: SteadiSet Extended Wear Infusion Set (a device that delivers insulin continuously for up to 7 days)
What this could lead to: If successful, this could allow people with type 1 diabetes to change their insulin infusion set only once a week instead of every 2-3 days, making daily management easier.
What could go wrong: This is a completed study, but results are not yet published. The device may not last the full 7 days for everyone, and there is a risk of high blood sugar or ketones if it fails.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE1DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE1DIABETES

Contacts and locations

Locations

Barbara Davis Center

Aurora, Colorado, 80045, United States
Endocrine Research Solutions

Roswell, Georgia, 30076, United States
Henry Ford Health System

Detroit, Michigan, 48202, United States
Hoag Memorial Hospital Presbyterian

Newport Beach, California, 92663, United States
Icahn School of Medicine at Mt. Sinai

New York, New York, 10029, United States
International Diabetes Center - HealthPartners Institute

Minneapolis, Minnesota, 55416, United States
Massachusetts General Hospital

Boston, Massachusetts, 02114, United States
Mayo Clinic

Rochester, Minnesota, 55905, United States
Northwestern University

Evanston, Illinois, 60208, United States
Rainier Clinical Research Center

Renton, Washington, 98057, United States
Rocky Mountain Clinical Research

Idaho Falls, Idaho, 83404, United States
SUNY Upstate Medical University

Syracuse, New York, 13210, United States
Stanford University

Stanford, California, 94305, United States
Texas Diabetes and Endocrinology

Austin, Texas, 78731, United States
University of Washington

Seattle, Washington, 98109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.